SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-112359
Filing Date
2023-10-30
Accepted
2023-10-30 07:30:42
Documents
74
Period of Report
2023-10-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2329331d1_8k.htm   iXBRL 8-K 46128
2 EXHIBIT 4.1 tm2329331d1_ex4-1.htm EX-4.1 75459
3 EXHIBIT 10.1 tm2329331d1_ex10-1.htm EX-10.1 197874
4 EXHIBIT 10.2 tm2329331d1_ex10-2.htm EX-10.2 163079
5 EXHIBIT 99.1 tm2329331d1_ex99-1.htm EX-99.1 10912
6 EXHIBIT 99.2 tm2329331d1_ex99-2.htm EX-99.2 24700
7 EXHIBIT 99.3 tm2329331d1_ex99-3.htm EX-99.3 21564
8 EXHIBIT 99.4 tm2329331d1_ex99-4.htm EX-99.4 85837
12 GRAPHIC tm2329331d1_ex99-1img005.jpg GRAPHIC 5899
13 GRAPHIC tm2329331d1_ex99-2img006.jpg GRAPHIC 5899
14 GRAPHIC tm2329331d1_ex99-3img004.jpg GRAPHIC 5899
15 GRAPHIC tm2329331d1_ex99-4img001.jpg GRAPHIC 179410
16 GRAPHIC tm2329331d1_ex99-4img002.jpg GRAPHIC 654285
17 GRAPHIC tm2329331d1_ex99-4img003.jpg GRAPHIC 224855
18 GRAPHIC tm2329331d1_ex99-4img004.jpg GRAPHIC 153604
19 GRAPHIC tm2329331d1_ex99-4img005.jpg GRAPHIC 127175
20 GRAPHIC tm2329331d1_ex99-4img006.jpg GRAPHIC 204635
21 GRAPHIC tm2329331d1_ex99-4img007.jpg GRAPHIC 182311
22 GRAPHIC tm2329331d1_ex99-4img008.jpg GRAPHIC 42465
23 GRAPHIC tm2329331d1_ex99-4img009.jpg GRAPHIC 149707
24 GRAPHIC tm2329331d1_ex99-4img010.jpg GRAPHIC 164689
25 GRAPHIC tm2329331d1_ex99-4img011.jpg GRAPHIC 180222
26 GRAPHIC tm2329331d1_ex99-4img012.jpg GRAPHIC 46659
27 GRAPHIC tm2329331d1_ex99-4img013.jpg GRAPHIC 179736
28 GRAPHIC tm2329331d1_ex99-4img014.jpg GRAPHIC 185928
29 GRAPHIC tm2329331d1_ex99-4img015.jpg GRAPHIC 51430
30 GRAPHIC tm2329331d1_ex99-4img016.jpg GRAPHIC 217129
31 GRAPHIC tm2329331d1_ex99-4img017.jpg GRAPHIC 137055
32 GRAPHIC tm2329331d1_ex99-4img018.jpg GRAPHIC 110246
33 GRAPHIC tm2329331d1_ex99-4img019.jpg GRAPHIC 191162
34 GRAPHIC tm2329331d1_ex99-4img020.jpg GRAPHIC 202390
35 GRAPHIC tm2329331d1_ex99-4img021.jpg GRAPHIC 156301
36 GRAPHIC tm2329331d1_ex99-4img022.jpg GRAPHIC 148251
37 GRAPHIC tm2329331d1_ex99-4img023.jpg GRAPHIC 195219
38 GRAPHIC tm2329331d1_ex99-4img024.jpg GRAPHIC 129582
39 GRAPHIC tm2329331d1_ex99-4img025.jpg GRAPHIC 53089
40 GRAPHIC tm2329331d1_ex99-4img026.jpg GRAPHIC 159128
41 GRAPHIC tm2329331d1_ex99-4img027.jpg GRAPHIC 197164
42 GRAPHIC tm2329331d1_ex99-4img028.jpg GRAPHIC 144897
43 GRAPHIC tm2329331d1_ex99-4img029.jpg GRAPHIC 158397
44 GRAPHIC tm2329331d1_ex99-4img030.jpg GRAPHIC 112315
45 GRAPHIC tm2329331d1_ex99-4img031.jpg GRAPHIC 116479
46 GRAPHIC tm2329331d1_ex99-4img032.jpg GRAPHIC 45545
47 GRAPHIC tm2329331d1_ex99-4img033.jpg GRAPHIC 172582
48 GRAPHIC tm2329331d1_ex99-4img034.jpg GRAPHIC 247595
49 GRAPHIC tm2329331d1_ex99-4img035.jpg GRAPHIC 47837
50 GRAPHIC tm2329331d1_ex99-4img036.jpg GRAPHIC 46994
51 GRAPHIC tm2329331d1_ex99-4img037.jpg GRAPHIC 170255
52 GRAPHIC tm2329331d1_ex99-4img038.jpg GRAPHIC 138534
53 GRAPHIC tm2329331d1_ex99-4img039.jpg GRAPHIC 204131
54 GRAPHIC tm2329331d1_ex99-4img040.jpg GRAPHIC 53652
55 GRAPHIC tm2329331d1_ex99-4img041.jpg GRAPHIC 200753
56 GRAPHIC tm2329331d1_ex99-4img042.jpg GRAPHIC 200254
57 GRAPHIC tm2329331d1_ex99-4img043.jpg GRAPHIC 276325
58 GRAPHIC tm2329331d1_ex99-4img044.jpg GRAPHIC 170298
59 GRAPHIC tm2329331d1_ex99-4img045.jpg GRAPHIC 81278
60 GRAPHIC tm2329331d1_ex99-4img046.jpg GRAPHIC 149197
61 GRAPHIC tm2329331d1_ex99-4img047.jpg GRAPHIC 214909
62 GRAPHIC tm2329331d1_ex99-4img048.jpg GRAPHIC 217584
63 GRAPHIC tm2329331d1_ex99-4img049.jpg GRAPHIC 239909
64 GRAPHIC tm2329331d1_ex99-4img050.jpg GRAPHIC 149550
65 GRAPHIC tm2329331d1_ex99-4img051.jpg GRAPHIC 127240
66 GRAPHIC tm2329331d1_ex99-4img052.jpg GRAPHIC 60821
  Complete submission text file 0001104659-23-112359.txt   12525551

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA vyne-20231027.xsd EX-101.SCH 3042
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vyne-20231027_lab.xml EX-101.LAB 34240
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vyne-20231027_pre.xml EX-101.PRE 22377
68 EXTRACTED XBRL INSTANCE DOCUMENT tm2329331d1_8k_htm.xml XML 3408
Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38356 | Film No.: 231357204
SIC: 2834 Pharmaceutical Preparations